<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04948515</url>
  </required_header>
  <id_info>
    <org_study_id>Soh-Med-21-04-35</org_study_id>
    <nct_id>NCT04948515</nct_id>
  </id_info>
  <brief_title>Gene Polymorphism of IL17 and IL 23</brief_title>
  <acronym>COVID 19IL17</acronym>
  <official_title>Association Between Gene Polymorphism of IL17 and IL 23 in Patients With COVID 19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      rates are in such considerable amount among large population base. The pathogenesis of&#xD;
      COVID-19 implicates a potent inflammatory response, involving a complex group of mediators&#xD;
      including interleukins. These pleiotropic cytokines are secreted at the region of&#xD;
      inflammation and released into the circulation by a variety of different cell types,&#xD;
      including macrophages, lymphocytes, endothelial cells, epithelial cells during sepsis and&#xD;
      acute organ injuries. There has recently found a number of studies reporting that the&#xD;
      cytokine storms take part in the course of COVID-19&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim Of The Study&#xD;
&#xD;
        1. To evaluate if there is an association between the IL-17, IL-23 gene polymorphism in&#xD;
           Patients With COVID 19 by real-time PCR&#xD;
&#xD;
        2. To measure the serum level of IL17 by ELISA in COVID 19 patients by ELISA.&#xD;
&#xD;
        3. To detect if there is an association between gene polymorphism of IL17 and IL23 and&#xD;
           severity of a condition in patients with COVID 19 Study design: a cross-sectional study.&#xD;
&#xD;
      The blood samples will be collected from patient records in COVID19 isolation hospitals in&#xD;
      sohag governorate and isolation department in sohag university hospitals.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 3, 2021</start_date>
  <completion_date type="Anticipated">October 3, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>4 Months</target_duration>
  <primary_outcome>
    <measure>genotyping of IL 17</measure>
    <time_frame>3-6-2021 to 30-8-2021</time_frame>
    <description>real time pcr detection of different genotypes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>genotyping of IL 23</measure>
    <time_frame>3-6-2021 to 30-8-2021</time_frame>
    <description>real time pcr detection of different genotypes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>estimation of serum level of IL 17</measure>
    <time_frame>3-6-2021 to 30-8-2021</time_frame>
    <description>measuring serum level of IL 17 by ELISA</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>COVID-19 Respiratory Infection</condition>
  <arm_group>
    <arm_group_label>group 1 patients with severe covid 19 respiratory infections</arm_group_label>
    <description>Patients with severe covid 19 admitted to ICU, blood samples will be collected for testing different genotypes and serum level of IL 17</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 2 patients with non severe covid 19 respiratory infections</arm_group_label>
    <description>Patients with nonsevere covid 19 admitted to the internal ward, blood samples will be collected for testing different genotypes and serum level of IL 17</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>laboratory test</intervention_name>
    <description>genotyping of IL 17 and IL23</description>
    <arm_group_label>group 1 patients with severe covid 19 respiratory infections</arm_group_label>
    <arm_group_label>group 2 patients with non severe covid 19 respiratory infections</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>laboratory test</intervention_name>
    <description>estimation of serum level of IL 17</description>
    <arm_group_label>group 1 patients with severe covid 19 respiratory infections</arm_group_label>
    <arm_group_label>group 2 patients with non severe covid 19 respiratory infections</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood collected on EDITA tubes for genotyping by ELISA and serum blood on plane tubes&#xD;
      for ELISA&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        group 1 patients with covid 19 with severe infections admitted at ICU group 2 patients with&#xD;
        covid 19 with nonsevere infections admitted at internal wards&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with Covid19 positive PCR&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with Covid19 clinical criteria not confirmed by PCR&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>N S shafik, lecturer</last_name>
    <role>Principal Investigator</role>
    <affiliation>sohag university hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>N S Shafik, lecturer</last_name>
    <phone>01067261504</phone>
    <phone_ext>02</phone_ext>
    <email>Nohasaber@med.sohag.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>M M Abd El Rhman, lecturer</last_name>
    <phone>01021025859</phone>
    <phone_ext>02</phone_ext>
    <email>monamohamed@med.sohag.edu.eg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sohag University</name>
      <address>
        <city>Sohag</city>
        <zip>82733</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>N S Shafik, lecturer</last_name>
      <phone>01067261504</phone>
      <phone_ext>02</phone_ext>
      <email>Nohasaber@med.sohag.edu.eg</email>
    </contact>
    <contact_backup>
      <last_name>M M Abd El Rhman, lecturer</last_name>
      <phone>01021025859</phone>
      <phone_ext>02</phone_ext>
      <email>monamohamed@med.sohag.edu.eg</email>
    </contact_backup>
    <investigator>
      <last_name>A M Goda, Assistant professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>S B Hemdan, lecturer</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>M A Ahmed, lecturer</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>A A Abdel-baset, lecturer</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 24, 2021</study_first_submitted>
  <study_first_submitted_qc>June 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2021</study_first_posted>
  <last_update_submitted>June 24, 2021</last_update_submitted>
  <last_update_submitted_qc>June 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Noha Saber Shafik</investigator_full_name>
    <investigator_title>lecturer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Respiratory Tract Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>to protect the privacy of the patient</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

